FDA Inspection
Kwabena (NMI) Ayesu, M.D.Kwabena (NMI) Ayesu, M.D. – FDA Inspection, Jan 27, 2023
Record Details
This FDA Inspection record concerns Kwabena (NMI) Ayesu, M.D., with an inspection on January 27, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0ee2832f-03d0-4794-9d18-f1b97b7d0537
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1195661
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Unanticipated problems
- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Unanticipated problems
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kwabena (NMI) Ayesu, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 2, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 31, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Kwabena (NMI) Ayesu, M.D.
- FDA Inspection 1139836 - 2021-04-02
- FDA Inspection 1099885 - 2019-07-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.